chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2/18 Severe pain &tingling left big toe, 2/18 dizzy lightheaded , nausea, fatigue, swollen lymph node left under arm, pain/swelling/redness at site, decreased near vision(2days), mild temp increase99.6, chills, muscle/joint pain, Starting 2/21large/red/swollen/w warm/ severely itchy rash from shoulder to elbow of left arm(lasted approximately 3 week?s& occas. Itchy now), large/swollenlymph nodes under chin on vaccine side
This spontaneous report as received from a physician via an unspecified reporter, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 02-MAY-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 Single dose 0.5mLVls 10SDV" and lot number J011998 with expiration date of 12-FEB-2015 (route of administration was unknown), which was stored at -6.66 Celsius Degrees for 744 hours. The type of excursion was refrigerator and the vaccine status in excursion. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Deep pain in left shoulder joint immediately upon administration.  Pain continued to intensify over the next 30 - 45 minutes.  Dull pain in left shoulder, worse during the night.  Persists and is increased when raising arm, especially above head, rotating  arm out to left side or attempting to lift objects with left hand/arm
hot to the touch near/around injection site; red near/around injection site; itchy  near/around injection site; swollen near/around injection site; large local reaction 8 days after first injection; Red rash; reaction was red and warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (large local reaction 8 days after first injection), RASH ERYTHEMATOUS (Red rash), MILIARIA (reaction was red and warm to the touch), VACCINATION SITE WARMTH (hot to the touch near/around injection site) and VACCINATION SITE ERYTHEMA (red near/around injection site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C2114 and 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hay fever. Concurrent medical conditions included Food allergy (mushrooms-Shortness of breath, tight throat) since 2006 and Food allergy (seaweed-Shortness of breath, tight throat) since 2012.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 31-Mar-2021, the patient experienced SKIN REACTION (large local reaction 8 days after first injection), RASH ERYTHEMATOUS (Red rash) and MILIARIA (reaction was red and warm to the touch). On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot to the touch near/around injection site), VACCINATION SITE ERYTHEMA (red near/around injection site), VACCINATION SITE PRURITUS (itchy  near/around injection site) and VACCINATION SITE SWELLING (swollen near/around injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 4 Tab once a day and IBUPROFEN (ADVIL [IBUPROFEN]) from 01-Apr-2021 to 06-Apr-2021 at a dose of 6 Tab once a day. On 06-Apr-2021, SKIN REACTION (large local reaction 8 days after first injection), RASH ERYTHEMATOUS (Red rash) and MILIARIA (reaction was red and warm to the touch) had resolved. At the time of the report, VACCINATION SITE WARMTH (hot to the touch near/around injection site) and VACCINATION SITE ERYTHEMA (red near/around injection site) had not resolved and VACCINATION SITE PRURITUS (itchy  near/around injection site) and VACCINATION SITE SWELLING (swollen near/around injection site) outcome was unknown.            No concomitant medications were reported.    This case was linked to MOD-2021-069557.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow-Up was received on 08-JUL-2021 and contain Non-Significant information. On 16-Jul-2021: Significant follow up Added :-AE not resolved
Heart Palpitations are noticeable at night when laying down starting 12/8. started to feel them during the day sitting down working at computer 12/9. Felt heart skipping beats the night of 12/9.  Went skiing for 2 hours 12/10 and felt slightly short of breath, but still performed at my normal intensity (ski race intensity almost).  All up to this point, no chest pain, just general uncomfortableness.  Checked myself into ER on 12/10/2021. Took EKG, presented evidence of Premature Ventricular Contractions. 132/82 blood pressure. 96% Oxygen, 98.4 tempurature. 66 pulse. Blood panel results all within normal ranges.  Given IV of lactated Ringer's bolus, then released from ER.
temperature excursion involving multiple lot numbers for GARDASIL 9, MMR II, ROTATEQ, and RECOMBIV AX. Many of the vaccines have been administered to patients; No further AE; This spontaneous report was received from a practice manager and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported. On 13-AUG-2020, the patient was vaccinated with improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 injection, lot # R021636 was confirmed to be valid with expiration date 12-MAY-2021(exact dose, route of administration, anatomical location were not reported) for prophylaxis.  The temperature excursion was below 2 Celsius degrees (C) (1.1 C) for 27 hours and 45 minutes and above 9 C for 1 hour and 15 minutes (29 hours cumulative). The digital data logger was involved. No adverse effects were reported.  This is one of two reports received from the same reporter.  combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: R021636; expirationdate: 12-MAY-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other;  followupadditionalinfo :Yes; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2010USA001083:
chills; myalgias; fatigue; increased cough; This is a spontaneous report from a contactable physician(patient). A 58-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), intramuscular on 11Dec2020 18:00 at left arm at single dose for COVID-19 immunization. Medical history included COVID-19 diagnosed prior to vaccination and cough. No other medical history. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine but received other medications within 2 weeks of vaccination. The patient previously took ilosone and experienced allergies. The patient experienced chills, myalgias, fatigue and increased cough on 12Dec2020 14:00. No treatment received for the events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering.
pt recv vax 6/2/99 & parent called MD evening of 6/2/99 to report pt had been crying & screaming approx 5hr;parent giving pt APAP;calmed down during MD/parent conversation;
Patient was in office for treatment of a burn and a Tdap was ordered. Medical assistant administered a Kinrix (Dtap, IPV) instead.
March 14th, I awoke vomiting, with fever, diarrhea, muscle aches. This lasted for 5 days
Right deltoid edematous, warm, tender to palpation, erythema from shoulder to elbow.
Patient given 3rd dose of HPV9 (received #1 HPV4, #2 HPV9 prior) and sent to waiting room to do 15 minute wait period. Patient had syncope while seated on mom's lap had seizure and was incontinent of urine. Pt seen by CRNP VSS rested in office for 30 mins. Sent home.
Many, many DVT blood clots in my left leg and groin area.  In hospital 3 days.  Upon arrival at hospital via ambulance I was in Kidney failure and was dehydrated. Had a procedure to remove all the DVT's they could get to, and am now on Eliquis for the rest of my life at $40 a month.  I still have chronic DVT's.
Pt came into store said arm started itching yesterday-also is red and swollen told her to go to walk in clinic if Dr could not see her.
Subsequently, the pt was exposed to a child with chickenpox and developed ten lesions on his abdomen.
Swelling to left upper arm noted with associated erythema spanning 13cm x 10cm. Patient complains to pruritis; Benadryl PRN itchiness prescribed.
Patient was fine Friday but he started to throw up on Saturday at 2pm for no apparent reason and no fever. He then proceeded to throw up again Monday morning at 2am and complained of his stomach hurting very badly even after vomiting.
I was exhausted and very sick, ran a fever, and threw up multiple times. I felt that way all day Saturday and Sunday and only started to feel better on Monday
Patient came in for immunization on October 9,2017. Then came back on October 12, 2017 to show me a large rash she had developed around the injection site. She said that it had started on October 11, 2017 and that it was very red and a little raised. She said that as the days progressed, it was getting a little better.
Vertigo after 20 hours of injection. two days later still have vertigo.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8736) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included fatty liver and primary biliary cholangitis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ursodeoxycholic acid (URSODIOL) for unknown indication on unknown date and unknown if ongoing. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: GP7533) via an unspecified route of administration in the left arm on 26Mar2021 at 10:45 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 00:00, 20 hours after vaccination, the patient experienced vertigo. Two days later still the patient had vertigo. The event did not result in doctor or other healthcare professional office/clinic visit.  No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo was not recovered at the time of the this report.  No follow-up attempts are needed. No further information is expected.
Patient stated felt nauseous and fatigue (on  9/27/17) about 1 day after the flu vaccine. Spoke to patient on 10/3/17 and patient still had nausea and fatigue (fatigue is more prominent on 10/3/17 because patient have not been able to eat). Patient went to visit doctor and was given Zofran. Called patient back twice to on 10/7/17 to check patient's status (pt did NOT pick up phone).
Patient says on 10/24/23 she noticed her lips were swollen for 2 days.  She stated she has hives on her back, stomach, legs, and neck.  She said those areas  (back and stomach) were hot, red, and itchy.
Hot, red, swollen on 11-07-06. Swollen part in lower arm. Inside of elbow still today (11-8-06) still not as bad. Take 50mg of Benadryl tonight.
Tingling and numbness of tongue about 2 hrs after injection; Tingling and numbness of tongue about 2 hrs after injection; Soreness at site of injection for 1 day; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (Formulation: Solution for injection), via an unknown route of administration on 28Jan2021 as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced tingling and numbness of tongue about 2hrs after injection and soreness at site of injection for 1 day on 28Jan2021. The outcome of the event tingling and numbness of tongue about 2hrs after injection was recovered on 28Jan2021 and soreness at site of injection for 1 day was recovered on 29Jan2021.  Follow-up attempts are completed. No further information is expected.
Fever and rash 8 days after MMR and varivax. I do not have lot #'s secondary to patient receiveing at health department.
fever of around 99 in the morning, 100 during the day; chills; I had little energy; annoying headache; mild pain; barely slept, tossing and turning all night; This is a spontaneous report received from a non-contactable consumer (patient). A 25-year-old non-pregnant female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0170), via an unspecified route of administration, administered in left arm on 26Apr2021 at 13:15 (at the age of 25-year-old), as DOSE 2, SINGLE for COVID-19 immunization at Public Health Clinic/Veterans Administration facility. The patient was not pregnant at the time of vaccination. The patient medical history included ADHD (attention deficit hyperactivity disorder), lactose, IBS (irritable bowel syndrome). Concomitant medications included METHYLPHENIDATE HYDROCHLORIDE and BUSPIRONE. Historical vaccine included first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0150), via an unspecified route of administration, administered in left arm on 05Apr2021 at 14:15 (at the age of 25-year-old), as DOSE 1, SINGLE for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Apr2021, the patient experienced mild pain and barely slept, tossing and turning all night. On 27Apr2021, the patient experienced fever of around 99 in the morning, 100 during the day, chills, little energy and annoying headache. The outcome of the event (I had little energy) was unknown and other events was recovered on an unspecified date in Apr2021.  No follow-up attempts are needed. No further information is expected.
No adverse event; Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 12-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster).    Concomitant drugs were not reported. It was reported that patient received 0.25 mL of bivalent booster dose instead of 0.5 mL and stated that reporter called the CDC and were instructed to go ahead and administer the other half of the dose on the same day. Treatment medications were not provided. This case was reported for the adult patient 11.   This case was linked to US-MODERNATX, INC.-MOD-2022-658149, US-MODERNATX, INC.-MOD-2022-658139, US-MODERNATX, INC.-MOD-2022-658150, US-MODERNATX, INC.-MOD-2022-658155, US-MODERNATX, INC.-MOD-2022-658154, US-MODERNATX, INC.-MOD-2022-658156, US-MODERNATX, INC.-MOD-2022-658157, US-MODERNATX, INC.-MOD-2022-658159, US-MODERNATX, INC.-MOD-2022-658162, US-MODERNATX, INC.-MOD-2022-658168, US-MODERNATX, INC.-MOD-2022-658173, US-MODERNATX, INC.-MOD-2022-658152, US-MODERNATX, INC.-MOD-2022-658158, US-MODERNATX, INC.-MOD-2022-658161 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-658139:Adult patient 1 US-MODERNATX, INC.-MOD-2022-658149:Adult patient 2 US-MODERNATX, INC.-MOD-2022-658150:Adult patient 3 US-MODERNATX, INC.-MOD-2022-658154:Adult patient 5 US-MODERNATX, INC.-MOD-2022-658155:Adult patient 6 US-MODERNATX, INC.-MOD-2022-658156:Adult patient 7 US-MODERNATX, INC.-MOD-2022-658157:Adult patient 8 US-MODERNATX, INC.-MOD-2022-658159:Adult patient 10 US-MODERNATX, INC.-MOD-2022-658162:Adult patient 13 US-MODERNATX, INC.-MOD-2022-658168:Adult patient 14 US-MODERNATX, INC.-MOD-2022-658173:Adult patient 15 US-MODERNATX, INC.-MOD-2022-658152:Adult patient 4 US-MODERNATX, INC.-MOD-2022-658158:Adult patient 9 US-MODERNATX, INC.-MOD-2022-658161:Adult patient 12
Around 30 hours after my 3rd injection I started experiencing difficulty controlling my bowels and my legs got extremely heavy and it became difficult to walk or move my legs while seated or laying down. My heart rate was 188 bpm while laying down and would randomly spike every few minutes. My clonidine barely brought it down with additional emergency dosages. Usually the clonidine keeps my post-COVID heart rate down enough for me to still function well enough on my own. On the 15th, I started experiencing head congestion and by the end of the day, or severe chest congestion. I now have a fever, a cough, runny nose, bowel issues, and severe muscle and joint pain. The pain in my herniated disc?s section (T9-12) is much more painful and tight. I am vomiting and have diarrhea/constipation as well. Sweats and chills. Chest pain and tightness. More severe pain in ribs.
AFTER RECEIVING FIRST DOSE MODERNA, PATIENT REPORTS FEELING DIZZY AND JULD SHORTNESS OF BREATH, , PT HAS ALLERGIES TO TO GENERAL ANASTHESIA, BENADRYL AND SEASONAL ALLERGIES  UPON AMBULATION PATIENT REPORTS FEELING NAUSEOUS, DIZZY, WEAKNESS OF BILATERAL LEGS.
Patient started to get an annoying, moderate headache on the morning of Sat 12/8/2018 which has affected some day to day activities. The headache has continued at this time with no relief from ibuprofen 200mg 1-2 tablets as needed.
Pain at injection site increasing to next day. Fatigue, headache (brain fog). Numbness in left side of face noticed morning of 3/31. Not full paralysis. No face drooping.
ADMINISTRATION ERROR: PATIENT RECEIVES BOOSTER DOSE WITH THE MODERN VACCINE (0.25ml) - ACCORDING TO THE AGE, THEY SHOULD RECEIVE THE PFIZER VACCINE, FOLLOWING THE ESTABLISHED GUIDELINES FOR REINFORCEMENT.
Headache; Chills; Fatigue; Right arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right arm pain), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 028L20A) for COVID-19 vaccination.     No medical history was reported.    On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Right arm pain). On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Right arm pain) had not resolved and HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue) had resolved.            No Concomitant  information was  provided. No Treatment information was  provided.
Site of inj is tender than usual and appears to be rashy - redness - swelling.
PATIENT STATES THAT DAY AFTER VACCINE SHE NOTICED A 1.5 INCH BY 5 INCH RAISED RED AREA AROUND THE VACCINATION SITE. I ASKED PATIENT TO REPORT BACK IF THE AREA REMAINED AFTER TODAY OR GOT LARGER. I TOLD HER THAT THIS IS SOMETIMES A REACTION THAT OCCURS WITH THIS VACCINATION
12:05- vaccine given, 12:06 pt passed out, lasting 15-30 sec, then vomited, pale, weak pulse, HR 74, 94/65, doctor with peds accepted pt into peds, was transferred at 12:20pm
Migraine headaches for 2 weeks without any relief. Have taken ibuprofen, aspirin. Even tried SUDAFED and nasal spray simply saline. No relief. Headache 7/10-> 8/10. Neck pain (R) side. Shot taken on 10/26. on Wednesday 11/4 vertigo started and has continued. Blurred vision on 10/27 and comes and goes. Father had Meniere disease.
Patient received Flu vaccine in left upper arm on 10/6/15. She was seen in our office on 10/8/15 for pain, swelling, and redness extending from upper arm to elbow. Patient was advised to use cool compresses as needed.
Patient reports having developed a fever of 104 degrees.  Went to emergency room.  Was admitted to hospital for 1-2 night stay and reports receiving IV antibiotics for treatment of cellulitis.  Patient discharged from hospital after 2 days with prescription for oral clindamycin.  (all information was reported to us by the patient)
Intusseption, bloody stool, vomitting of bile, stomach cramps, pain 8/31/07 Received vax record from pcp.  VAERS database updated w/same./ss 9/28/07 Vax record faxed to CDC.  10/5/07 T/C to hospital to check status of request.  States records faxed directly to CDC on 10/2/07.  10/5/07 Received hospital medical records which reveal patient experienced pallor, decreased bowel sounds, bilious vomiting, blood in stool & abdominal pain.  Admitted 8/18-8/19/2007 for observation.  Surgery consult done. reduction.  Progressed well & d/c to home. FINAL DX: Intussusception.
allergic reaction: hives, itching over approx 20% of body, irrupting over a span of a 1/2 hour; R eye swollen overnite
Patient was being treated at local Medical Center for Covid-19 PNA with hypoxic respiratory failure but showed no improvement despite all interventions. Patient was on max Airvo 100% flow rate of 60L, patient was also encephalopathic, head CT was negative for any acute process. Patient transferred to hospice care service and was placed on comfort care. Patient expired on 08/17/2021.
Chills, mild fever, body aches and fatigue about 12 hours after the shot.  Fever abated the following morning but returned that afternoon about 24 hours after the shot.  Took Tylenol which relieved all symptoms so then slept better that night.  The following day seemed back to normal with no more symptoms.
Left chest pain radiating to left arm, into armpit, and up into left ear. Burning aching pain that intensifies with activity, caffeine,  and deep breathing.  Vomiting on 4/26 with nausea and loose bowels continuing on 4/27. Continuous sweats, lightheadedness, and periodic left sided headache. Was since by medical team on 4/30/21 and evaluated for ear or sinus infection which were ruled out.  Lungs sounded clear and no abnormal vitals or bowel sounds.